Benefit of standard versus low-dose tirofiban for percutaneous coronary intervention in very elderly patients with high-risk acute coronary syndrome.

Age and outcomes of primary percutaneous intervention for ST elevation myocardial infarction in a tertiary center-are we there yet? J Geriatr Cardiol (2015) 0.75

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol (2007) 10.19

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med (2001) 9.31

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med (1985) 7.29

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J (2007) 6.51

The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med (1998) 3.74

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation (2006) 3.22

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA (2007) 3.07

Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J (2005) 2.94

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol (1988) 2.60

Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation (2007) 2.42

Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol (2005) 2.16

Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol (2006) 1.94

Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J (2008) 1.86

Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profile. J Am Coll Cardiol (2003) 1.49

Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial. J Am Coll Cardiol (2006) 1.20

Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.05

Pharmacodynamics and pharmacokinetics of the platelet GPIIb/IIIa inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage. Thromb Res (2004) 0.83

Coronary interventions in the elderly. Heart (2006) 0.79

Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease. BMC Complement Altern Med (2014) 0.91

Comparison of long-term clinical outcome between transcatheter Amplatzer occlusion and surgical closure of isolated patent ductus arteriosus. Chin Med J (Engl) (2009) 0.89

A novel hemostatic sealant composed of gelatin, transglutaminase and thrombin effectively controls liver trauma-induced bleeding in dogs. Acta Pharmacol Sin (2013) 0.81

[Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules]. Zhonghua Yi Xue Za Zhi (2010) 0.81

[Comparison of tilt and decentration of four different kinds of aspheric intraocular lenses implantation]. Zhonghua Yan Ke Za Zhi (2010) 0.80

Characterization of papillary thyroid microcarcinomas using sonographic features in malignant papillary thyroid cancer: a retrospective analysis. Medicine (Baltimore) (2015) 0.79

[Clinicopathological features and prognostic implications of EGFR/c-Met gene copy number and protein expression in non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi (2010) 0.78

[Biosorption of Pb2+ and Cu2+ by an exopolysaccharide from the deep-sea psychrophilic bacterium Pseudoalteromonas sp. SM9913]. Huan Jing Ke Xue (2009) 0.78

Interventricular septum motion abnormalities: unexpected echocardiographic changes of Brugada syndrome. Chin Med J (Engl) (2007) 0.77

[Causes and management of ischemic-type biliary lesion after orthotopic liver transplantation]. Zhonghua Yi Xue Za Zhi (2011) 0.77

[Study of effect of Humifuse Euphorbia Herb on alleviating insulin resistance in type 2 diabetic model KK-Ay mice]. Zhongguo Zhong Yao Za Zhi (2015) 0.76

Elevated Human Endothelial Cell-Specific Molecule-1 Level and Its Association With Coronary Artery Disease in Patients With Hypertension. J Investig Med (2015) 0.76

[Time course of myocardial NF-kappaB activation post coronary microembolization]. Zhonghua Xin Xue Guan Bing Za Zhi (2008) 0.75

[Precondition with doxycycline administration abates ischemia/reperfusion injury and reduces the expression of matrix metalloproteinase-1/9 in myocardium in rat in vivo]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2007) 0.75

[Correction of the secondary deformity after reduction mammaplasty]. Zhonghua Zheng Xing Wai Ke Za Zhi (2005) 0.75

[CYP1A1 rs4646422 gene polymorphisms not correlated with male infertility in Chinese Han population]. Zhonghua Nan Ke Xue (2016) 0.75

[Flow cytometry for evaluation of sperm plasma membrane integrity in varicocele patients]. Zhonghua Nan Ke Xue (2011) 0.75

Efficacy of homemade hemostatics of injected gelatin matrix for immediately treating blunt hepatic trauma in canine model without additional pressure. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2012) 0.75

[Changes of gene expressions in patients with hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi (2007) 0.75

[The design and technique of one stage treatment of eyelid divided nevus with island skin flap]. Zhonghua Zheng Xing Wai Ke Za Zhi (2010) 0.75

[Effects of hydroxyethyl starch 130/0.4 on P38 mitogen-activated protein kinases signal transduction pathway]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2009) 0.75

[Increased lectin-like oxidized low density lipoprotein receptor-1 expression in the autologous vein grafts and vein graft atherosclerosis]. Zhonghua Xin Xue Guan Bing Za Zhi (2006) 0.75

[Relativity of nuclear factor-kappaB (P65/Rel-A) and angiotensin II type 1 receptor expression in early stage of lesions of adriamycin nephrosis in young rats and the effects of intervention]. Zhonghua Er Ke Za Zhi (2004) 0.75

[Awareness on SARS and public health emergencies among general publics]. Zhonghua Liu Xing Bing Xue Za Zhi (2006) 0.75

[Municipal wastewater treatment using a composite flocculant made of polyaluminum chloride and polydimethyldiallyammonium chloride]. Huan Jing Ke Xue (2007) 0.75

[Protective effect of "neiguan" (PC 6)-electroacupuncture preconditioning on the myocardium in myocardial ischemia/reperfusion rats]. Zhen Ci Yan Jiu (2010) 0.75

[Life in Attendance--Record of Prof. WANG Xue-mei, Peking University First Hospital]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2016) 0.75

Modified culotte stenting for treatment of complex coronary bifurcation lesions: immediate and 9-month outcomes in a pilot study. Chin Med J (Engl) (2011) 0.75

[In vivo confocal microscopy study of corneal endotheliitis]. Zhonghua Yan Ke Za Zhi (2012) 0.75

[Ablation of segmental glissonian pedicle by ultrasound-guided radiofrequency in precision liver resection in a porcine model]. Zhonghua Wai Ke Za Zhi (2012) 0.75

[Protective effect of carnosine on the injury of rat vascular endothelial cells induced by hypoxia]. Zhongguo Ying Yong Sheng Li Xue Za Zhi (2010) 0.75

[Localized expressing tendency of nuclear transcription factor kappa-B, pro-fibrosis genetic factors and fibronectin mRNA in renal tissues in proteinuria overload nephrotic young rats]. Zhonghua Er Ke Za Zhi (2005) 0.75

[Immunological effects of polyacrylamide hydrogel injection in human body]. Zhonghua Zheng Xing Wai Ke Za Zhi (2004) 0.75

[Optimizing the operating variables that affect the transfection experiment of antisense oligodeoxyribonucleotide by gas-filled microbubbles]. Yao Xue Xue Bao (2007) 0.75

Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions. Chin Med J (Engl) (2008) 0.75

[Echogenic phospholipids-based gas-filled microbubbles as delivery system of antisense oligodeoxynucleotides]. Yao Xue Xue Bao (2006) 0.75

[Relationship between autophagy and T2DM and intervention effect of traditional Chinese medicine]. Zhongguo Zhong Yao Za Zhi (2015) 0.75

[Liver stiffness measured by acoustic radiation force impulse imaging in assessing hepatic functional reserve in patients with space-occupying lesions in the liver]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (2013) 0.75